Cell culture media (CCM) drive the productivity of upstream processes and help ensure critical quality attributes of the final drug product. Because of this critical role in manufacturing, along with increased regulatory focus on raw materials, it is recommended that media be included in drug product risk assessments.1,2
To ease the burden of collecting the extensive information needed for a thorough assessment, Cellvento® CHO cell culture media are included in our Emprove® Program.
As part of the Emprove® Program, cell culture media in our Emprove® CCM portfolio include comprehensive dossiers that facilitate your process optimization, risk assessment, and quality efforts.
Material Qualification Dossier
Quality Management Dossier
Operational Excellence Dossier
Unlock all the benefits of the Emprove® Program by subscribing to our Emprove® Suite. Available exclusively for subscribers, all dossiers of the entire Emprove® portfolio can be accessed at your convenience.
To subscribe today, simply complete and submit the reply form below after reading our Emprove® terms and conditions.
Subscribe to the Emprove® Suite
Tool: Risk Mitigation and Quality Requirements: Support for Bioprocesses